Ocular surface alterations and in vivo confocal microscopic characteristics of corneas in patients with myasthenia gravis

Abstract

Purpose:

To evaluate ocular surface alterations and characteristics of corneal basal epithelium and subbasal nerves in patients with myasthenia gravis.

Materials and methods:

Myasthenia gravis patients (n = 21) and healthy controls (n = 20) were enrolled. All participants underwent ocular surface testing in the following order: tear break-up time, lissamine green staining, Schirmer I test with anesthesia, and Ocular Surface Disease Index questionnaire. The Cochet-Bonnet esthesiometer was used to measure corneal sensitivity. Basal epithelial cells and subbasal nerves were evaluated using in vivo confocal microscopy.

Results:

Myasthenia gravis patients had higher Ocular Surface Disease Index score (13.9 ± 15.0 vs 1.4 ± 2.2, p < 0.001) and lissamine green staining score (0.6 ± 0.4 vs 0.2 ± 0.4, p = 0.007). Break-up time score (9.3 ± 3.0 vs 9.9 ± 1.9, p = 0.481) and Schirmer I test score (16.5 ± 9.2 vs 19.3 ± 8.4, p = 0.323) did not differ significantly. Corneal sensation was 0.4 g/mm² in all eyes. Patients with myasthenia gravis had lower basal epithelial cell density (3775.7 ± 938.1 vs 4983.1 ± 608.5, p < 0.001) and total nerve density (1956.1 ± 373.3 vs 2277.9 ± 405.0, p = 0.012) and higher subbasal nerve tortuosity (1.9 ± 0.8 vs 1.6 ± 0.7, p = 0.007) than controls. A significant increase in Ocular Surface Disease Index scores was found with decreasing basal epithelial cell density (rho = −0.518, p = 0.001). There was a significantly moderate negative correlation between the duration of myasthenia gravis and the number of corneal nerves (rho = −0.497, p = 0.022).

Conclusion:

Significant alterations of basal epithelial cells and subbasal nerves were demonstrated in myasthenia gravis patients although there was no difference of corneal sensitivity between myasthenia gravis patients and healthy controls. Thus, it should be borne in mind that myasthenia gravis patients deserve further evaluation with regard to ocular surface disease.

Keywords

Basal epithelium confocal microscopy corneal nerves myasthenia gravis ocular surface disease

Get full access to this article

View all access options for this article.

References

Gilhus

Verschuuren

JJ.

Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 2015; 14: 1023–1036.

Vincent

Palace

Hilton-Jones

Myasthenia gravis. Lancet 2001; 357: 2122–2128.

Gwathmey

Burns

TM.

Myasthenia gravis. Semin Neurol 2015; 35: 327–339.

Verschuuren

Huijbers

Plomp

et al . Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmun Rev 2013; 12: 918–923.

Müller

Marfurt

Kruse

et al . Corneal nerves: structure, contents and function. Exp Eye Res 2003; 76: 521–542.

Chernyavsky

Galitovskiy

Shchepotin

et al . The acetylcholine signaling network of corneal epithelium and its role in regulation of random and directional migration of corneal epithelial cells. Invest Ophthalmol Vis Sci 2014; 55: 6921–6933.

Nazarian

O’Leary

Corneal sensitivity in myasthenia gravis. Br J Ophthalmol 1985; 69: 519–521.

Kocabeyoglu

Mocan

Cevik

et al . Ocular surface alterations and in vivo confocal microscopic features of corneas in patients with newly diagnosed Graves’ disease. Cornea 2015; 34: 745–749.

Methodologies to diagnose monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop. Ocul Surf 2007; 5: 108–152.

10.

Lum

Golebiowski

Swarbrick

HA.

Reduced corneal sensitivity and sub-basal nerve density in long-term orthokeratology lens wear. Eye Contact Lens 2017; 43: 218–224.

11.

Schiffman

Christianson

Jacobsen

et al . Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118: 615–621.

12.

Mocan

Durukan

Irkec

et al . Morphologic alterations of both the stromal and subbasal nerves in the corneas of patients with diabetes. Cornea 2006; 25: 769–773.

13.

Oliveira-Soto

Efron

Morphology of corneal nerves using confocal microscopy. Cornea 2001; 20: 374–384.

14.

Villani

Galimberti

Viola

et al . The cornea in Sjogren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci 2007; 48: 2017–2022.

15.

Kocabeyoglu

Karadag

Mocan

et al . Orbital involvement and ocular surface changes in IgG4-related systemic disease. Cornea 2016; 35: 1449–1453.

16.

Wang

et al . Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol 2012; 90: 663–668.

17.

Benítez del Castillo

Wasfy

Fernandez

et al . An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 2004; 45: 3030–3035.

18.

Villani

Galimberti

Viola

et al . Corneal involvement in rheumatoid arthritis: an in vivo confocal study. Invest Ophthalmol Vis Sci 2008; 49: 560–564.

19.

Niederer

McGhee

CNJ

. Clinical in vivo confocal microscopy of the human cornea in health and disease. Prog Retin Eye Res 2010; 29: 30–58.

20.

Labbé

Alalwani

Van Went

et al . The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci 2012; 53: 4926–4631.

21.

Tuisku

Konttinen

et al . Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren’s syndrome. Exp Eye Res 2008; 86: 879–885.

22.

Vernino

Cheshire

Lennon

VA.

Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci 2001; 88: 187–192.

23.

Tabbaa

Leshner

Campbell

WW.

Malignant thymoma with dysautonomia and disordered neuromuscular transmission. Arch Neurol 1986; 43: 955–957.

24.

Senda

Sugimura

Koike

et al . Concurrence of acute autonomic and sensory neuropathy and myasthenia gravis-a case report and pathogenetic considerations. Rinsho Shinkeigaku 1989; 29: 332–335.